JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hogg, R. C.
Right arrow Articles by Adams, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hogg, R. C.
Right arrow Articles by Adams, D. J.

Vol. 289, Issue 3, 1502-1508, June 1999

Mechanisms of Verapamil Inhibition of Action Potential Firing in Rat Intracardiac Ganglion Neurons1

R. C. Hogg, C. Trequattrini, L. Catacuzzeno, A. Petris, F. Franciolini and D. J. Adams

Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland, Australia (R.C.H., D.J.A.); and Dipartmento Biologia Cellulare e Molecolare, Universita' di Perugia, Perugia, Italy (C.T., L.C., A.P., F.F.)


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The effects of verapamil and related phenylalkylamines on neuronal excitability were investigated in isolated neurons of rat intracardiac ganglia using whole-cell perforated patch-clamp recording. Verapamil (>= 10 µM) inhibits tonic firing observed in response to depolarizing current pulses at 22°C. The inhibition of discharge activity is not due to block of voltage-dependent Ca2+ channels because firing is not affected by 100 µM Cd2+. The K+ channel inhibitors charybdotoxin (100 nM), 4-aminopyridine (0.5 mM), apamin (30-100 nM), and tetraethylammonium ions (1 mM) also have no effect on firing behavior at 22°C. Verapamil does not antagonize the acetylcholine-induced inhibition of the muscarine-sensitive K+ current (M-current) in rat intracardiac neurons. Verapamil inhibits the delayed outwardly rectifying K+ current with an IC50 value of 11 µM, which is approximately 7-fold more potent than its inhibition of high voltage-activated Ca2+ channel currents. These data suggest that verapamil inhibits tonic firing in rat intracardiac neurons primarily via inhibition of delayed outwardly rectifying K+ current. Verapamil inhibition of action potential firing in intracardiac neurons may contribute, in part, to verapamil-induced tachycardia.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Postganglionic neurons of mammalian intracardiac ganglia mediate vagal innervation of the heart, forming functional afferent, efferent, and local circuits responding to neural and humoral substances to influence heart rate (Moravec and Moravec, 1989; Armour, 1991). In neonatal rat intracardiac ganglia, >90% of neurons display tonic or slowly adapting action potential firing in response to a depolarizing current pulse at 22°C (Cuevas et al., 1997). At 37°C, these neurons display rapidly adapting action potential firing to a depolarizing current pulse. The discharge activity of intracardiac neurons can be modulated by acetylcholine (ACh), which is the primary neurotransmitter involved in the vagal innervation of the heart.

Verapamil, a derivative of papaverine, is a class IV antiarrhythmic commonly used for the treatment of supraventricular tachyarrhythmias. The antiarrhythmic effects of verapamil are most marked on the atrioventricular node, making it effective in the treatment of atrial fibrillation and paroxysmal supraventricular tachyarrhythmias (Witt and Cranefield, 1974). Verapamil inhibits Ca2+ entry through high voltage-activated L-type Ca2+ channels in cardiac myocytes to slow the firing of pacemaker cells in the sinoatrial node, shorten the plateau phase of the action potential, and slow impulse propagation, increasing the refractory period of the atrioventricular node (for a review, see Nademanee and Singh, 1988).

Several studies have recently reported that verapamil also inhibits delayed rectifier K+ currents [IK(DR)] in a number of tissues, including rat alveolar epithelial cells (DeCoursey, 1995), chick embryo dorsal root ganglion neurons (Trequattrini et al., 1996, 1998a), K+ channels cloned from human heart (Rampe et al., 1993), and mouse mKv1.3 channels (Rauer and Grissmer, 1996). In the present study, the effects of verapamil on action potential firing behavior and ionic currents were investigated in isolated neurons from neonatal rat intracardiac ganglia. Verapamil inhibits tonic action potential firing observed at 22°C and in the presence of muscarinic ACh receptor stimulation. Although verapamil partially inhibits high voltage-activated Ca2+ channel currents in rat intracardiac neurons, it attenuates action potential firing at low concentrations (<= 10 µM), primarily through inhibition of IK(DR). Preliminary reports of some of these results have been published (Hogg and Adams, 1997; Trequattrini et al., 1998b).

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell Preparation. Parasympathetic neurons from neonatal rat intracardiac ganglia were isolated and cultured as described previously (Xu and Adams, 1992a). Briefly, 2- to 8-day-old rats were stunned and decapitated, and the hearts were excised and placed in a saline solution containing 140 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 0.6 mM MgCl2, 7.7 mM glucose, and 10 mM histidine, pH 7.2. The atria were separated, and the medial region containing the pulmonary veins and superior vena cava was identified, isolated, and incubated in the above saline solution, containing 1 mg·ml-1 collagenase (Type 2, activity ~200 U·mg-1; Worthington Biochemical Corp., Freehold, NJ). After enzyme digestion, the ganglia were removed, and neurons were dispersed by trituration in a high glucose culture medium [Dulbecco's modified Eagle's medium, containing 10% (v/v) FCS, 100 U·ml-1 penicillin, and 0.1 mg·ml-1 streptomycin] using a fire-polished pasteur pipette. The dissociated neurons were plated onto laminin-coated glass coverslips and incubated at 37°C in a 95% air/5% CO2 atmosphere for 24 to 72 h. For experimentation, coverslips containing dissociated neurons were transferred to a perfusion chamber (0.5 ml volume) mounted on an inverted microscope, and individual cells were identified under 400× magnification using phase-contrast optics.

Electrophysiological Recording. Current and voltage recordings were made using the whole-cell recording configuration of the patch-clamp technique (Hamill et al., 1981). Electrical access to the cell interior was obtained using either the perforated-patch configuration (Horn and Marty, 1988) or the conventional (dialyzed) whole-cell recording configuration for recording voltage-dependent Na+ and Ca2+ currents. The perforated-patch configuration allows electrical access to the cell interior without the loss of cytoplasmic components, which is important in maintaining functional responses in these cells. A stock solution of 60 mg·ml-1 amphotericin B in dimethyl sulfoxide was prepared on the day of the experiment and was diluted in the pipette solution to yield a final concentration of 240 µg·ml-1 amphotericin B in 0.4% dimethyl sulfoxide. The tip of the pipette first was filled with antibiotic-free solution to prevent any disruption of seal formation and then was backfilled with the amphotericin B-containing solution. Pipettes were pulled from thin-walled borosilicate glass (Clark Electromedical Instruments, Reading, UK) using a Sutter instruments P-87 pipette puller and after fire polishing had resistances of ~1 MOmega . Access resistances using the perforated patch configuration were typically 4 to 8 MOmega before series resistance compensation of 60% to 80%.

Membrane currents and voltages were recorded using an Axopatch 200A patch-clamp amplifier (Axon Instruments Inc., Foster City, CA), filtered at 2 to 10 kHz (-3 dB, Bessel filter), digitized at 10 to 50 kHz (Digidata 1200 interface; Axon Instruments Inc.), and stored on a PC (Pentium, 100 MHz) for viewing and analysis. Voltage and current protocols were applied, and data acquisition and analysis were carried out using pClamp software (Version 6.1.2; Axon Instruments Inc.). Depolarization-activated ionic currents were elicited with voltage steps from a holding potential of -100 to -60 mV to more positive potentials. Capacitive transients were minimized by using analog circuitry of the amplifier, and leak currents were subtracted with a -P/4 protocol. Dose-response curves were obtained by measuring either the peak inward Ba2+ current or steady-state outward K+ current amplitude at each antagonist concentration, and the experimental data points were fit using the equation:
<UP>I/I<SUB>max</SUB></UP>=1/[1+([A]/<UP>IC</UP><SUB>50</SUB>)<SUP>n</SUP>]+<UP>I</UP><SUB>0</SUB> (1)
where I/Imax is the relative current, [A] is the antagonist concentration, IC50 is the concentration giving half-maximal inhibition, n is the Hill coefficient, and I0 is the current remaining in the presence of a maximally effective concentration of antagonist.

Numerical data are presented as the mean ± S.E. (where n is number of observations).

Solutions. The pipette filling solution for perforated patch experiments contained 75 mM K2SO4, 55 mM KCl, 5 mM MgSO4, and 10 mM HEPES, titrated with N-methyl-D-glucamine to pH 7.2. In the dialyzed whole-cell recording configuration, the pipette solution contained 140 mM KCl, 2 mM MgATP, 10 mM K4-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, and 10 mM HEPES-KOH, pH 7.2. The pipette solution used to record voltage-activated Ca2+ channel currents using the conventional whole-cell configuration contained 100 mM CsCl2, 10 mM Na4-1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 2 mM MgATP, 0.2 mM GTP, and 40 mM HEPES-CsOH, pH 7.2. The control extracellular solution contained 140 mM NaCl, 3 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 7.7 mM glucose, and 10 mM HEPES-NaOH, pH 7.2. In experiments to examine IK(DR), 300 nM tetrodotoxin (TTX) and 0.1 mM CdCl2 were included in the extracellular solution. Depolarization-activated Ca2+ channel currents were isolated in the presence of 300 nM TTX, 5 mM tetraethylammonium ions (TEA)-Cl, and 10 mM BaCl2. The muscarine-sensitive K+ current (M-current [IM]) was isolated as described previously using extracellular solutions containing 3 mM CsCl, 1 mM 4-aminopyridine, and 300 nM TTX (Cuevas et al., 1997). Experiments were carried out at 22°C except where indicated otherwise. The osmolality of all solutions was monitored with a vapor pressure osmometer (5500; Wescor, Logan, UT) and was in the range of 285 to 295 mmol·kg-1.

Reagents. All chemicals used were of analytical grade. All drugs were applied by bath application except where indicated. The drugs methoxyverapamil hydrochloride (D600), (±)-verapamil hydrochloride, acetylcholine chloride, mecamylamine hydrochloride, apamin, TEA, ATP, and GTP were supplied by Sigma Chemical Co. (St. Louis, MO). 4-Aminopyridine (4-AP) was from Aldrich Chemical Co. (Milwaukee, WI). Charybdotoxin (ChTX) was from Auspep (Parkville, Victoria, Australia). D890 (LU 44280) was from Knoll AG-Ludwigshafen. TTX was from Calbiochem-Novabiochem Pty. Ltd.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effects of Verapamil on Action Potential and Firing Discharge Activity

The effect of verapamil on action potential firing at 22°C was investigated using the perforated patch recording configuration in >70 neonatal rat intracardiac neurons. The average resting membrane potential was -52 mV and was unchanged in the presence of 10 to 100 µM verapamil (data not shown). At 22°C, neonatal rat intracardiac neurons respond to suprathreshold depolarizing current pulses with either a slowly adapting or a tonic discharge (Fig. 1A; Cuevas et al., 1997). Bath application of verapamil (>= 10 µM) reversibly reduced the number of action potentials in response to a 100-pA depolarizing current pulse (Fig. 1, B and C). Verapamil also altered the action potential waveform, whereby the peak amplitude of the afterhyperpolarization is reduced and a slower rate of depolarization during the interspike interval was observed (Fig. 1D). A mild slowing of the rate of action potential repolarization (14.4 versus 19.6 mV·ms-1) was also consistently observed.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   The effect of verapamil on action potentials and discharge activity in rat intracardiac neurons at 22°C. Action potential firing evoked by a depolarizing current pulse of 150 pA, in the absence (A) and the presence (B) of 10 µM and 100 µM (C) verapamil. D, superimposed traces of action potentials recorded from the same cell in the absence (light trace) and presence (dark trace) of 10 µM verapamil. Resting membrane potential, -52 mV.

In contrast, at 37°C, no changes in the rate of firing were observed in response to a depolarizing current step in the absence or presence of 100 µM verapamil (Fig. 2, A and B). Phasic action potential firing in rat intracardiac neurons in response to a depolarizing current pulse has previously been attributed to the presence of an IM at 37°C (Xi-Moy and Dun, 1995; Cuevas et al., 1997). The application of 100 µM ACh together with 3 µM mecamylamine (to block neuronal nicotinic ACh receptor activation) to the cell soma at 37°C inhibits IM and induces tonic firing (Fig. 2C). Tonic firing in the presence of ACh is reversibly inhibited in the presence of 100 µM verapamil, as shown in Fig. 2, D and E. Given that verapamil has been reported to competitively antagonize muscarinic ACh receptors (Karliner et al., 1982; Baumgold, 1986), the effect of verapamil on IM in the absence and presence of ACh was examined at both 22°C and 37°C. At 22°C, the kinetics of IM are slowed and its amplitude is reduced, resulting in tonic firing. In five cells, bath application of verapamil (100 µM) did not affect IM or its inhibition by ACh (100 µM ACh plus 3 µM mecamylamine). ACh reduced IM by approximately 30% in the absence and presence of 100 µM verapamil at both temperatures (n = 5, data not shown).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Verapamil antagonism of ACh-induced action potential firing in neonatal rat intracardiac neurons at 37°C. A, action potential firing at 37°C in response to a 150-pA depolarizing current pulse. Resting membrane potential, -50 mV. B, verapamil (100 µM) has no effect on firing in response to a depolarizing current pulse. C, tonic firing induced by bath application of 100 µM ACh and 3 µM mecamylamine. D, tonic firing induced by 100 µM ACh is inhibited in the presence of 100 µM verapamil. E, recovery of ACh-induced tonic firing after washout of verapamil.

To assess the effect of a Ca2+ channel blocker on action potential firing at 22°C, 0.1 mM Cd2+, which completely blocks depolarization-activated Ca2+ currents in rat intracardiac neurons (Xu and Adams, 1992b; Jeong and Wurster, 1997), was bath applied and had no effect on firing behavior (n = 6, data not shown). Similarly, the K+ channel inhibitors ChTX (100 nM), 4-AP (0.5 mM), apamin (30-100 nM), and TEA (1 mM) also had no effect on action potential firing (Cuevas et al., 1997). The effect of verapamil on voltage-dependent Na+ currents was also examined in rat intracardiac neurons, but these currents were unaffected by bath application of 10 to 100 µM verapamil (n = 4; data not shown).

Effects of Verapamil on Voltage-Activated Ca2+ and K+ Channel Currents

The effect of verapamil on the high voltage-activated Ca2+ channel current in rat intracardiac neurons is shown in Fig. 3A. Bath application of 10 to 300 µM verapamil reversibly inhibited the Ba2+ current elicited by step depolarization from -100 mV to +20 mV. Verapamil inhibits the Ba2+ current in a concentration-dependent manner with an IC50 value of 78 µM (n >=  4; Fig. 3B). The inward Ba2+ current remaining in the presence of 0.3 to 1 mM verapamil was completely inhibited by 100 µM Cd2+ (Fig. 3A).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Verapamil inhibition of high voltage-activated Ca2+ channel currents. A, superimposed traces of depolarization-activated Ba2+ currents obtained in the absence (control) and presence of 10, 100, and 300 µM verapamil. Inward Ba2+ currents were evoked at +20 mV from a holding potential of -100 mV and were completely abolished by bath application of 100 µM Cd2+. B, dose-response relationship for verapamil inhibition of peak Ba2+ currents. Data points represent mean ± S.E. obtained from four to six cells. Continuous line represents the best fit of the data by eq. 1 with an IC50 value of 78 µM (Hill coefficient = 0.65).

Bath application of verapamil inhibited IK(DR) in a concentration-dependent manner as shown in Fig. 4A. Verapamil induced a rapid, dose-dependent decay of the current to a new steady-state level without affecting its rising rate, suggesting a state-dependent block. A dose-response curve was obtained by applying depolarizing voltage pulses of sufficient duration (225-500 ms) to reach steady-state block in the presence of varying concentrations of verapamil. Half-maximal inhibition of IK(DR) by verapamil occurred at 11 µM (n >=  3; Fig. 4B), which is approximately 7-fold more potent than that for verapamil inhibition of high voltage-activated Ca2+ channel currents.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Dose-dependent inhibition of IK(DR) by verapamil. A, superimposed traces of delayed rectifier outward K+ currents obtained at +80 mV in the absence (control) and presence of verapamil. Verapamil concentrations were applied cumulatively from 3 to 100 µM to the same neuron. Holding potential, -80 mV. B, dose-response relationship obtained for verapamil steady-state inhibition of normalized IK(DR) amplitude obtained by voltage steps to +80 mV from a holding potential of -80 mV. Data points represent mean ± S.E. obtained from at least three cells. Continuous line represents represents the best fit of the data by eq. 1 with an IC50 value of 11 µM (Hill coefficient = 0.9).

The effect of the related phenylalkylamines, D600 and its permanently charged quaternary derivative D890, on action potential firing and IK(DR) was also examined. Bath application of 100 µM D890 did not affect firing in response to a depolarizing current pulse (Fig. 5B), whereas 100 µM D600 attenuated discharge activity (Fig. 5C). The relative abilities of 100 µM D600 and D890 to inhibit IK(DR) are compared in Fig. 5D. Under voltage-clamp conditions, the amplitude of IK(DR) elicited on depolarization to +80 mV was reduced in the presence of D600 but not D890 (Fig. 5D). The ability of the phenylalkylamines to reduce action potential firing appears to correlate with their potency to inhibit IK(DR).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 5.   The effect of the phenylalkylamines D600 and D890 on action potential firing and IK(DR) at 22°C. Action potential firing evoked by a 150-pA depolarizing current pulse in the absence (A) and the presence of 100 µM D890 (B) and 100 µM D600 (C). D, superimposed traces of IK(DR) obtained at +80 mV (holding potential, -80 mV) in the absence (control) and presence of D600 (100 µM) and D890 (100 µM).

Verapamil Block of Delayed-Rectifier K+ Currents

Given that verapamil block of IK(DR) appears to underlie the inhibition of action potential firing, the characteristics of verapamil block of IK(DR) were investigated. Figure 6 shows the effects of 30 µM verapamil on IK(DR) evoked by depolarizing pulses from a holding potential of -80 mV to test potentials between -40 and +80 mV. As also shown at voltages positive to 0 mV (see Fig. 4A), verapamil caused a dramatic change in the time course of IK(DR); the current activated to a maximum then decayed with time to a small fraction of its peak value (Fig. 6B). In contrast, no change was observed in the activation kinetics of the current. The decay of the current was well fitted by a single exponential.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Characteristics of verapamil block of IK(DR). Families of currents evoked by depolarizing pulses from -60 to +80 mV in 20-mV steps in control conditions from a holding potential of -70 mV in the absence (A, control) and in the presence of 30 µM verapamil (B). C, plot of the voltage dependence of activation of IK(DR) () and the relative IK(DR) amplitude obtained in the presence of 30 µM verapamil (open circle ) as a function of membrane potential. D, the rate of block (1/tau b), obtained by single-exponential fit of the current decay from experiments similar to that shown in Fig. 4A is plotted as function of verapamil concentration. Data points represent the mean ± S.E. from five cells; error bars are within symbols. Block and unblock rate constants, at +80 mV, given by the slope and the y-axis intercept of the regression line, were 0.67 ± 0.04 ms-1·mM-1 and 0.0075 ± 0.008 ms-1.

Figure 6C shows the activation curve of the IK(DR) (filled symbols) together with the steady-state fractional block of the current as a function of the membrane potential (open symbols). Block increased steeply between -20 mV and +20 mV, the voltage range of channel activation, whereas it was approximately stable at membrane potentials more positive than +40 mV, where all channels are open. This indicates that block may be directly linked to the gating process (compare with Snyders et al., 1991), as expected for a state-dependent block in which the drug can bind to the channel only in the open state according to the kinetic scheme:
C <AR><R><C>&agr;</C></R><R><C>⇌</C></R><R><C>&bgr;</C></R></AR> O <AR><R><C>k<SUB><UP>on</UP></SUB>[B]</C></R><R><C>⇌</C></R><R><C>k<SUB><UP>off</UP></SUB></C></R></AR> O · B (2)
where C, O, and O·B are the closed, open, and open-blocked states; [B] is the blocker concentration; and alpha , beta , kon, and koff are the rate constants for the transitions between states. A prediction of this model is that the rate of current decay is dependent on the blocker concentration. This prediction is tested by an experiment of the type shown in Fig. 4A. The plot shown in Fig. 6D demonstrates that the decay rate (1/tau ) exhibits a linear dependence on verapamil concentration.

Kinetic Constants of Verapamil Block

The block and unblock rate constants, kon and koff, were estimated from the verapamil-induced current decay (Fig. 6D) as previously described for verapamil block of IK(DR) (Rampe et al., 1993; Trequattrini et al., 1998a). Interference from the concurrent inactivation process (tau  congruent  3-4 s) can be neglected compared with the much faster current decay (tau b < 150 ms) induced by verapamil. Given that at high depolarizing voltages (+80 mV) channel activation occurs with a time constant (<4 ms) more than 3-fold lower than tau b, the decay of the current in the presence of verapamil represents the process of channel block. Under these conditions, block and unblock rate constants can be estimated using the relation 1/tau b = (kon[B] koff), where tau b is the time constant of verapamil-induced current decay. Using this relation, kon and koff values are obtained from the slope and the intercept, respectively, of the linear regression of 1/tau b versus verapamil concentration. The block and unblock rate constants obtained from five neurons were 0.67 ± 0.04 ms-1·mM-1 and 0.0075 ± 0.008 ms-1, respectively. These rate constants give a value of 11 µM for the dissociation constant (KD = koff/kon), consistent with that obtained from steady-state measurements.

Voltage Dependence of Block and Unblock Rate Constants

The voltage dependence of verapamil block was assessed from the rate of block, 1/tau b, and from the steady-state block, IVerapamil/IControl, at different voltages. To minimize possible errors in the measurement of the voltage dependence of block introduced by the shift in gating equilibrium (see Trequattrini et al., 1996), test pulses to voltages between +105 and +45 mV (15-mV steps) were preceded by a depolarizing prepulse (+120 mV, for 25 ms) where channel activation was maximal under control conditions (Fig. 7A). This protocol would rapidly activate all channels, thus uncoupling the activation process from block. The block rate constants, after the addition of 30 µM verapamil, were assessed by solving the equation given by the time constant of block (1/tau b = (kon[B] + koff) and the steady-state block {IVerapamil/IControl = 1/(1+ [B]/[koff/kon])} at varying test voltages (assuming that block involves the binding of one molecule per channel). The rate constants kon and koff were found to be uniform over the voltage range examined (Fig. 7B), indicating verapamil block is not voltage dependent. This method was used because it allows kon and koff to be calculated at various potentials using only one concentration of verapamil. The estimate of kon and koff, as they appear in Fig. 7B are consistent with those derived from Fig. 6D using the method described previously.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Voltage dependence of verapamil block of IK(DR). A, IK(DR) elicited in response to a 25-ms depolarizing pulse to +120 mV from a holding potential of -80 mV, followed by a test pulse varying from +105 to +45 mV in 15-mV increments. Same stimulus protocol as in control after the addition of 30 µM verapamil. B, verapamil block (black-square) and unblock () rate constants, calculated from decay rate of the current and steady-state of block, respectively (n = 4), are plotted against membrane potential. Data are expressed as mean ± S.E.; error bars are within symbols. C, a double-pulse protocol used to assess recovery of IK(DR) after block by verapamil as function of time. A 200-ms conditioning pulse to +80 mV was separated from a second test pulse by a variable period during which the cell was repolarized to -80 mV. The percent of peak current recovered (ITest/IConditioning) is plotted against interpulse duration (n = 4 for each point). Data points were fitted by a double-exponential function giving time constants of tau 1 = 0.4 s and tau 2 = 4.12 s, respectively. Data are expressed as mean ± S.E.; error bars are within the symbols.

The time course of recovery from block by verapamil occurring at repolarized potentials was assessed by using a double-pulse protocol. The recovery during the interpulse period at -80 mV was measured as the ratio between the peak current of the second (test) pulse and the peak current of the first (conditioning) pulse. Figure 7C shows that recovery from block follows a double exponential time course with time constants of 0.4 and 4.12 s. The effects of increased external K+ concentration on the onset and recovery from block were also examined because external K+ has been shown to rise considerably during prolonged firing and has been shown to significantly affect the kinetics of block in several preparations (Armstrong, 1971; DeCoursey, 1995). Raising external K+ to 30 mM did not significantly change either the decay rate of IK(DR) or recovery from block by verapamil (data not shown).

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Verapamil (1-100 µM) reversibly attenuates tonic action potential firing observed in neonatal rat intracardiac neurons both at 22°C and after muscarinic receptor stimulation at 37°C. which may occur in vivo during prolonged vagal stimulation. Verapamil, however, has no effect on rapidly adapting firing observed in response to depolarizing current pulses at 37°C. The firing behavior of neonatal rat intracardiac neurons is highly temperature dependent and modulated by ACh via IM (Cuevas et al., 1997). At 37°C, neurons rapidly adapt in response to a depolarizing current step, but in the presence of ACh or a muscarinic receptor agonist, IM is depressed and a depolarizing current step elicits tonic action potential firing. IM is largely inactivated at 22°C, and in response to membrane depolarization, neurons fire repetitively. Verapamil has been reported to antagonize the binding of agonists to muscarinic ACh receptors in rat brain (Baumgold, 1986; Katayama et al., 1987) and heart (Karliner et al., 1982) and muscarinic ACh receptor activation of K+ currents in guinea pig atrial myocytes (Ito et al., 1989). In rat intracardiac neurons, verapamil failed to have any effect on IM in the absence or presence of ACh, suggesting that verapamil inhibition of ACh-induced tonic firing observed in these neurons at 22° and 37°C is not due to antagonism of muscarinic receptor activation. The inhibition of ACh-induced firing by verapamil appears to involve a verapamil-sensitive current other than IM that may also modulate neuronal excitability in rat intracardiac ganglia.

The inhibition of discharge activity is not due to block of voltage-gated Ca2+ or Ca2+-dependent K+ channels because firing is not affected by 0.1 mM Cd2+, 100 nM ChTX, 0.5 mM 4-AP, 30-100 nM apamin, and 1 mM TEA. Given that voltage-dependent Na+ currents and IM are also unaffected by verapamil, inhibition of the discharge activity in these neurons by verapamil most likely occurs through block of IK(DR). Inhibition of IK(DR) by verapamil occurs with an IC50 value of 11 µM, which is similar to that determined in chick DRG neurons (4 µM; Trequattrini et al., 1996) and for delayed rectifier K+ channels cloned from human heart (21 µM; Rampe et al., 1993).

An effect attributable to IK(DR) inhibition is the reduced amplitude of the action potential afterhyperpolarization, which will slow the rate of Na+ channel (voltage-dependent) recovery from inactivation and increase the threshold for action potential firing. This effect of verapamil on Na+ current time course, secondary to IK(DR) inhibition, is consistent with a slower rate of depolarization and reduced overshoot of the subsequent action potential (see Fig. 1). The slower rate of depolarization associated with the increased interval between action potentials observed in the presence of verapamil may also be due, in part, to inhibition of the voltage-activated Ca2+ conductance, which would be reduced ~15% by 10 µM verapamil. An IC50 value of 78 µM was obtained for verapamil inhibition of the depolarization-activated Ba2+ current, indicating that verapamil is approximately 7-fold more potent in inhibiting IK(DR) compared with high voltage-activated Ca2+ channel currents.

The phenylalkylamine D600, but not the permanently charged D890, inhibited tonic action potential firing at 22°C with similar potency to their inhibitory effects on IK(DR). The effectiveness of the different phenylalkylamines to block IK(DR) also correlates with their ability to cross the plasma membrane, suggesting that the binding site on the IK(DR) channel is not located on the external part of the channel. Externally applied verapamil has been proposed to reach an internal binding site by partitioning into the lipid phase of the membrane (DeCoursey, 1995). Furthermore, the verapamil binding site on IK(DR) channels has been identified as part of the inner mouth of the K+ channel pore (Rampe et al., 1993).

The block of IK(DR) by verapamil is consistent with a state-dependent block in which the drug binds preferentially to the open state of the IK(DR) channel as reported previously (Rampe et al., 1993; DeCoursey, 1995; Trequattrini et al., 1996). However, the biexponential time course of recovery from block (see Fig. 7C) is not compatible with this simple three-state model unless an additional state, into which open-blocked channels can pass, is included. Previous studies have suggested such an additional state to be either an inactivated-blocked state (DeCoursey, 1995) or a closed-blocked state (Armstrong, 1971; Trequattrini et al., 1998a). The block of IK(DR) in rat intracardiac ganglion neurons has similar kinetics to that seen in chick embryo DRG neurons (Trequattrini et al., 1998a) and rat alveolar epithelial cells (DeCoursey, 1995).

Inhibition of action potential firing in parasympathetic neurons of intracardiac ganglia may be expected to reduce the bradycardia associated with vagal nerve stimulation in vivo, leading to tachycardia. Verapamil has been shown to cause a concentration-dependent increase in heart rate in conscious dogs (Nakaya et al., 1983) and has been reported to inhibit the bradycardic response to stimulation of the right vagal nerve in anesthetized neonatal pigs (Lee et al., 1985). Tachycardia, which is often observed on administration of verapamil to conscious animals, can be inhibited by autonomic block with atropine and propranolol but not with propranolol alone (Nakaya et al., 1983). The present data indicate that verapamil-induced inhibition of action potential firing in parasympathetic neurons may contribute, in part, to verapamil-induced tachycardia.

    Footnotes

Accepted for publication February 22, 1999.

Received for publication February 22, 1999.

1 This work was supported by National Health and Medical Research Council of Australia Grant 961138 (to D.J.A.) and Grant 92.689.CT04 from Italian Consiglio Nazionale Ricerch (to F.F.).

Send reprint requests to: Dr. David J. Adams, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia. E-mail: dadams{at}plpk.uq.edu.au

    Abbreviations

ACh, acetylcholine; IK(DR), delayed rectifier K+ currents; IM, muscarine-sensitive K+ current; TTX, tetrodotoxin; TEA, tetraethylammonium ions; D600, methoxyverapamil hydrochloride; 4-AP, 4-aminopyridine; ChTX, charybdotoxin.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/99/2893-1502$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Zhang and J. Cuevas
{sigma} Receptor Activation Blocks Potassium Channels and Depresses Neuroexcitability in Rat Intracardiac Neurons
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1387 - 1396.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Sculptoreanu, N. Yoshimura, and W. C. de Groat
KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide] Enhances A-Type K+ Currents in Neurons of the Dorsal Root Ganglion of the Adult Rat
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Rybalchenko, N. Prevarskaya, F. Van Coppenolle, G. Legrand, L. Lemonnier, X. Le Bourhis, and R. Skryma
Verapamil Inhibits Proliferation of LNCaP Human Prostate Cancer Cells Influencing K+ Channel Gating
Mol. Pharmacol., June 1, 2001; 59(6): 1376 - 1387.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hogg, R. C.
Right arrow Articles by Adams, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hogg, R. C.
Right arrow Articles by Adams, D. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition